Track topics on Twitter Track topics that are important to you
OptraSCAN, the leading end-to-end digital pathology solution provider, announced that US Patent and Trademark Office (USPTO) has granted a patent to OptraSCAN’s invention, titled ‘Method of Detect...
OptraSCAN claims to be the developer of world’s first on-demand digital pathology system to deliver fully integrated, affordable systems & solutions. OS-SiA is set to be the first The post Op...
“This collaboration is the next step forward in a healthcare eco-system that combines the advanced digital pathology capabilities offered by OptraSCAN and the exceptional histopathology and cytology...
OptraSCAN®, the leading end-to-end digital pathology solution provider, today announced that U.S. Patent and Trademark Office (USPTO) has granted a patent to OptraSCAN’s invention, titled ‘Metho...
World’s first smart scanner that scans and analyzes the tissue at the same time OptraSCAN®, the leading end-to-end digital pathology solution provider, today announced the launch of OS-SiA, a new...
OptraSCAN® Inc., global digital pathology solutions provider, and Neuberg Diagnostics, one of the Top 4 Diagnostics Service Provider in India, today anno...
OptraSCAN (www.optrascan.com) for research-use-only, is the first On-Demand Digital Pathology System to provide a comprehensive, affordable, turnkey Digital Pathology solut...
OptraSCAN (www.optrascan.com) for research-use-only, is the first On-Demand Digital Pathology system to provide a comprehensive, affordable end-to-end Digital Pathology sol...
We have published hundreds of OptraSCAN Inc. news stories on BioPortfolio along with dozens of OptraSCAN Inc. Clinical Trials and PubMed Articles about OptraSCAN Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of OptraSCAN Inc. Companies in our database. You can also find out about relevant OptraSCAN Inc. Drugs and Medications on this site too.
Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...